Afghanistan Harm Reduction project supports the Government and Civil Society Organizations during COVID-19 pandemic.

People who use drugs face the same risks or even higher vulnerability to COVID-19 due to underlying health issues like pre-existing health problems, weak immune system, prevalence of chronic medical conditions and high level of physical and psychological morbidity. High level of stigmatization and marginalization associated with drug use and lack of access to housing may increase the risks further and also create barriers for promoting risk reduction measures. 

UNODC COAFG in close collaboration with the Government and CSOs is providing support to people who use drugs, ensuring continuity and sustainability of HIV prevention, treatment, care and support services during COVID-19 pandemic. The support includes development, translation and dissemination of specific technical guideline, SOPs and infographics on provision of HIV prevention services. In addition, COAFG coordinated with ANPASH, World Health Organization (WHO), United Nations Development Programme (UNDP), and community-based organizations  and ensured participation of programme managers, policy makers and service providers from Afghanistan to the series of  webinars organized by UNODC HIV/AIDS section together with WHO and UNAIDS at global, and regional level. These webinars were a good forum for the countries to share valuable experiences in how to ensure the continuity and sustainability and implement evidence-

based and human rights-based policies that ensure access to effective programmes for people who use drugs.

 

Funding source: UNAIDS